Dandoy Christopher E, Kukreja Kamlesh U, Gruppo Ralph A, Patel Manish N, Tarango Cristina
Division of Hematology, Cancer & Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, 3333 Burnet Ave., MLC 11027, Cincinnati, OH, 45229, USA.
Pediatr Radiol. 2015 Apr;45(5):719-26. doi: 10.1007/s00247-014-3209-4. Epub 2014 Nov 7.
Our center has developed a multidisciplinary approach to percutaneous endovascular thrombolysis with the goal of improving outcomes in children with thrombosis. There is little data describing the safety and efficacy of endovascular thrombolysis and the frequency of post-thrombotic syndrome after thrombolysis in children.
Retrospective analysis of children undergoing percutaneous endovascular thrombolysis to determine (1) the safety and efficacy of this procedure and (2) the frequency of the diagnosis of post-thrombotic syndrome after thrombolysis.
We reviewed the medical and imaging databases for children who underwent percutaneous endovascular thrombolysis for deep venous thrombosis (DVT) between November 2008 and June 2013 at our institution. Demographic data were reviewed for the technical success and complications of thrombolysis and the last assigned post-thrombotic syndrome score using standardized scoring tools.
Forty-one children ages 3 months to 21 years (median age: 15 years; 44% male) underwent percutaneous endovascular thrombolysis between November 2008 and June 2013. Upper extremity DVT occurred in 13 patients (32%); lower extremity DVT occurred in 28 patients (68%). All 41 patients received thrombolysis grading; 90% of those patients achieved greater than 50% thrombus lysis. Twenty-eight patients received formal post-thrombotic syndrome scoring and 4 (14%) met diagnostic criteria for post-thrombotic syndrome. One major bleeding episode and one pulmonary embolism occurred with no long-term sequelae.
Endovascular thrombolysis for DVT in children is safe, effective at thrombus removal and may reduce the incidence of post-thrombotic syndrome. Randomized or larger clinical trials would be needed to determine the long-term benefits of endovascular thrombolysis.
我们中心已开发出一种经皮血管内溶栓的多学科方法,目标是改善血栓形成患儿的治疗效果。关于儿童血管内溶栓的安全性和有效性以及溶栓后血栓形成后综合征的发生率,相关数据很少。
对接受经皮血管内溶栓的儿童进行回顾性分析,以确定(1)该手术的安全性和有效性,以及(2)溶栓后血栓形成后综合征的诊断频率。
我们回顾了2008年11月至2013年6月在我们机构接受经皮血管内溶栓治疗深静脉血栓形成(DVT)的儿童的医学和影像数据库。使用标准化评分工具,对溶栓的技术成功率、并发症以及最后指定的血栓形成后综合征评分的人口统计学数据进行了回顾。
2008年11月至2013年6月期间,41名年龄在3个月至21岁(中位年龄:15岁;44%为男性)的儿童接受了经皮血管内溶栓治疗。上肢DVT发生在13例患者中(32%);下肢DVT发生在28例患者中(68%)。所有41例患者均接受了溶栓分级;其中90%的患者血栓溶解率超过50%。28例患者接受了正式的血栓形成后综合征评分,4例(14%)符合血栓形成后综合征的诊断标准。发生了1次严重出血事件和1次肺栓塞,均无长期后遗症。
儿童DVT的血管内溶栓治疗是安全的,在清除血栓方面有效,并且可能降低血栓形成后综合征的发生率。需要进行随机或更大规模的临床试验来确定血管内溶栓的长期益处。